Sun Pharma posts 2 percent fall in Q1 profit
Global specialty sales, which accounted for 16.2 percent of total sales during the quarter, rose 21 percent percent in the quarter, the company said.;
Bengaluru: Sun Pharmaceutical Industries posted a nearly 2% fall in first-quarter profit on Thursday as higher expenses offset demand for its drugs and related products.
Consolidated net profit after tax at India's largest drugmaker by revenue came in at 20.23 billion rupees ($244.4 million) for the three months ended June 30, compared with 20.61 billion rupees a year earlier.
Analysts, on average, had expected a profit of 21.38 billion rupees, as per Refinitiv data.
The company, which makes popular consumer healthcare products such as Revital vitamin pills and pain relief gel Volini, said its total revenue from operations rose 11% to 119.41 billion rupees for the quarter.
Founded in 1983, Sun Pharma also makes generics, over-the-counter medications, anti-retrovirals and active pharmaceutical ingredients for chronic and acute treatments.
The company said research and development (R&D) expenses for the quarter rose 47.5% to 6.79 billion rupees, compared to 4.61 billion rupees a year ago.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.